The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,972,615 in first-year total cost, median $325,000.
Most frequent study sections
- Hemostasis, Thrombosis, Blood Cells and Transfusion Study Section[HTBT]4
- Basic Biology of Blood, Heart and Vasculature Study Section [BBHV]2
- Atherosclerosis and Vascular Inflammation Study Section[AVI]1
- Cellular and Molecular Immunology - A Study Section[CMIA]1
- Special Emphasis Panel[ZRG1 IVBH-B (02)]1
Most frequent institutions
- UNIVERSITY OF PENNSYLVANIA2
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
- BOSTON MEDICAL CENTER1
- MAYO CLINIC ROCHESTER1
- UNIVERSITY OF CALIFORNIA, SAN DIEGO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | G6PD Deficiency and Atherosclerosis1R01HL176892-01 | MCNAMARA, COLEEN AZIMRING, JAMES C. | UNIVERSITY OF VIRGINIA, VA | $323,000 | ZRG1 |
| 2025 | Netrin-1 promotes the expansion and function of human hematopoietic stem cells by supporting a pro-hematopoietic vascular niche1R01HL177599-01 | BUTLER, JASON MATHEW | UNIVERSITY OF FLORIDA, FL | $295,438 | HTBT |
| 2024 | Novel functions of plasminogen and its diverse cargo in blood1R01HL173598-01 | VICKERS, KASEY C | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $350,000 | AVI |
| 2023 | A Novel Bone Marrow Transplantation Approach for Sickle Cell Disease Using Targeted Marrow Irradiation1R01HL164895-01A1 | HUI, SUSANTA K | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $362,450 | HTBT |
| 2023 | Role of glutamine metabolism in Dendritic Cell Development1R01DK138827-01A1 | HALDAR, MALAY | UNIVERSITY OF PENNSYLVANIA, PA | $325,000 | CMIA |
| 2023 | Cell-extrinsic emergency myelopoiesis regulated by ABCB71R01HL167354-01A1 | MEDINA, KAY LYNNSHAPIRO, VIRGINIA SMITH | MAYO CLINIC ROCHESTER, MN | $322,800 | HTBT |
| 2023 | Transfer RNAs in Hematopoietic Stem Cell Function1R01HL165172-01A1 | ACKERMAN, SUSAN LSIGNER, ROBERT A.J. | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $316,000 | BBHV |
| 2022 | Targeting PGC-1a for the treatment of sickle cell disease1R01HL155451-01A1 | CUI, SHUAIYING | BOSTON MEDICAL CENTER, MA | $350,000 | HTBT |
| 2022 | Repressing TGFbeta family signaling to promote hematopoietic stem cell formation in the embryo1R01HL163265-01 | SPECK, NANCY | UNIVERSITY OF PENNSYLVANIA, PA | $327,927 | BBHV |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.